Subject: Research Article | Access | Essential medicines | RA1-1270 | Public aspects of medicine | South Africa | Availability | Private sector healthcare | Public sector healthcare | Affordability
Background Inadequate access to affordable essential medicines poses a challenge to achieving Universal Health Coverage. Access to essential medicines for children has been in the spotlight in recent research. However, information from the end users of medicines, i.e. p... View more
1.Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, ‘t Hoen EFM, Wagner AK, Yadav P, Reich MR. Essential medicines for universal health coverage. Lancet. 2016. 10.1016/S0140-6736(16)31599-9. Accessed 16 Nov 2016.
2.World Health Organization. WHO guideline on country pharmaceutical pricing policies. 2015. http://apps.who.int/medicinedocs/en/d/Js21016en/. Accessed 5 June 2017.
3.World Health Organization. Health financing for universal coverage. 2016. http://www.who.int/health_financing/universal_coverage_definition/en/. Accessed 27 Dec 2016.
4.World Health Organization. Constitution of the World Health Organization. 1946. http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf?ua=1. Accessed 1 June 2017.
5.United Nations. Universal declaration of human rights. 1948. http://www.ohchr.org/EN/UDHR/Documents/UDHR_Translations/eng.pdf. Accessed 1 June 2017.
6.World Health Organization. Access to essential medicines as part of the right to health. 2017. http://www.who.int/medicines/areas/human_rights/en/. Accessed 15 Jan 2017.
7.Woerkom MV, Piepenbrink H, Godman B, Metz JD, Campbell S, Bennie M, et al. Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. J Comp Effectiveness Res. 2012. doi:10.2217/cer.12.52.
8.Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon Outcomes Res. doi:10.1586/1473722.214.171.124.
9.Novartis Global. Kenya first country to launch 'Novartis Access', expanding affordable treatment options against chronic diseases. 2015. https://www.novartis.com/news/media-releases/kenya-first-country-launch-novartis-access-expanding-affordable-treatment. Accessed 1 June 2017.
10.World Health Org anization. Essential medicines. 2017. http://www.who.int/topics/essential_medicines/en/. Accessed 19 Feb 2017.